Table 4 Patterns of multiple antibiotic resistance in different gastric diseases.
From: Analysis of Helicobacter pylori resistance in patients with different gastric diseases
Antibiotics | Superficial gastritis (n = 558) | Erosive gastritis (n = 1166) | Peptic ulcer (n = 560) | Atrophic gastritis (n = 510) | Intraepithelial neoplasia (n = 53) | Total (n = 2847) |
|---|---|---|---|---|---|---|
AMX + CLR | 7 (1.25%) | 17 (1.46%) | 6 (1.07%) | 6 (1.18%) | 2 (3.77%) | 38 (1.33%) |
AMX + LVX | 10 (1.79%) | 14 (1.20%) | 6 (1.07%) | 5 (0.98%) | 0 (0.00%) | 35 (1.23%) |
AMX + FR | 3 (0.54%) | 2 (0.17%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 5 (0.18%) |
CLR + LVX | 77 (13.80%) | 250 (21.44%) | 86 (15.36%) | 88 (17.25%) | 7 (13.21%) | 508 (17.84%) |
CLR + FR | 5 (0.90%) | 28 (2.40%) | 2 (0.36%) | 9 (1.76%) | 0 (0.00%) | 44 (1.55%) |
LVX + FR | 11 (1.97%) | 27 (2.32%) | 25 (4.46%) | 46 (9.02%) | 0 (0.00%) | 109 (3.83%) |
AMX + CLR + LVX | 11 (1.97%) | 28 (2.40%) | 9 (1.61%) | 21 (4.12%) | 2 (3.77%) | 71 (2.49%) |
AMX + CLR + FR | 0 (0.00%) | 4 (0.34%) | 2 (0.36%) | 1 (0.20%) | 3 (5.66%) | 10 (0.35%) |
AMX + LVX + FR | 2 (0.36%) | 6 (0.51%) | 6 (1.07%) | 3 (0.59%) | 0 (0.00%) | 17 (0.60%) |
CLR + LVX + FR | 8 (1.43%) | 25 (2.14%) | 20 (3.57%) | 32 (6.27%) | 1 (1.89%) | 86 (3.02%) |
AMX + CLR + LVX + FR | 4 (0.72%) | 5 (0.43%) | 2 (0.36%) | 6 (1.18%) | 1 (1.89%) | 18 (0.63%) |
